Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels.
about
Why Does Exercise "Trigger" Adaptive Protective Responses in the Heart?Anaesthetics as cardioprotectants: translatability and mechanismProspects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor AgonistsCardioprotection with kappa-opioid receptor stimulation is associated with a slowing of cross-bridge cyclingDiscovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioningExercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanismPharmacological delayed preconditioning against ischaemia-induced ventricular arrhythmias: effect of an adenosine A(1)-receptor agonistOpioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats.Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats.Essential activation of PKC-delta in opioid-initiated cardioprotection.Partial hindlimb occlusion reduced the susceptibility to sustained ventricular tachycardia in conscious rats.Role of bradykinin in preconditioning and protection of the ischaemic myocardium.Preconditioning - endogenous defence mechanisms of the heart.The protective effects of a phosphodiesterase 5 inhibitor, sildenafil, on postresuscitation cardiac dysfunction of cardiac arrest: metabolic evidence from microdialysis.Therapeutic receptor targets of ischemic preconditioning.Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists.Role of high-mobility group box-1 in myocardial ischemia/reperfusion injury and the effect of ethyl pyruvate.Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heartAdministration of a CO-releasing molecule induces late preconditioning against myocardial infarction.Delayed adaptation of the heart to stress: late preconditioning.Role of Endogenous Opioid System in Ischemic-Induced Late Preconditioning.Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors.K(ATP) channels mediate the antihypertrophic effects afforded by κ-opioid receptor stimulation in neonatal rat ventricular myocytes.Acute and chronic cardioprotection by the enkephalin analogue, Eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channelsIntravenous anesthesia for the patient with left ventricular dysfunction.Chronic sildenafil in men with diabetes and erectile dysfunction.Perspectives in innate and acquired cardioprotection: cardioprotection acquired through exercise.Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium.Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits.The second window of preconditioning (SWOP) where are we now?Exercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart.Non-peptidic δ opioid receptor agonists and antagonists (2000 - 2012).Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery.Cardioprotection acquired through exercise: the role of ischemic preconditioning.Preconditioning with the BKCa Channel Activator NS-1619 Prevents Ischemia/Reperfusion-Induced Inflammation and Mucosal Barrier Dysfunction: ROS and HO-1.Delta Opioid Receptors and Cardioprotection.Effect of tramadol on lung injury induced by skeletal muscle ischemia-reperfusion: an experimental study.Characterization of human cardiac mitochondrial ATP-sensitive potassium channel and its regulation by phorbol ester in vitro.Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial.Roles of KATP channels in delayed cardioprotection and intracellular Ca(2+) in the rat heart as revealed by kappa-opioid receptor stimulation with U50488H.
P2860
Q26775499-62342328-F5BC-43B0-82A6-3B0D88B9D518Q26863637-9F30E084-5FC3-46B5-B1E9-C793B0D5759EQ28066192-46C28D98-B7E2-43C2-B42A-ABC32C503D83Q28139895-DA7BF7AB-0B20-4E9B-8846-61EE1B45A751Q28193545-5C4C2C4A-86EE-4327-8185-3A7EDE05CDB7Q28349059-65F8AF10-42B8-4F84-A3EF-A9A9D16216EEQ28365419-3EE75415-5824-4841-916B-F676F3033574Q30441793-61A86DFF-3732-4B9E-8AA5-549FEFB39DE8Q31723631-C9A74C5D-73BA-4BE0-B8E5-6EA23B1EA1AEQ31941069-9913FD6F-8FCC-445F-A697-871DC38BBCC4Q33498729-2FD6624A-2C66-43B1-A7B3-A425E644AFA4Q34542200-6D11D23B-212E-4B81-9606-4F9407D87778Q34593774-72B3D993-4731-4C37-AE6D-8FDCDF1F5B5AQ34676754-089148E3-75D6-425E-A730-7C0E4B90DDE9Q34772406-DF8542FE-AC14-4F2B-AA4F-827FAF8C6339Q34956769-46055AD6-B3CB-4474-920C-B148802A3417Q35159715-912BBEA0-01C0-4249-85EA-A177D557BACDQ35286353-1AE7950A-F646-4005-A763-865476599487Q35425229-84304307-E917-4C39-8D80-E4D26D13B9EFQ35622774-0D8FA9B9-9824-4E48-9229-1172B66F0586Q35727269-BCFEA489-8F78-40EF-A684-0A279F62089BQ35745405-D5CE27B0-14E5-4F49-B9FB-C04E6D730EC6Q36285561-5A32396B-6FFE-485D-B2C4-C442B46F8497Q36350926-5DFCC446-7D0D-44B8-AF71-3D349D96D903Q36480106-80F0D5EA-8A65-4F09-99C8-9F2FD2A24A18Q36835843-B38470DB-285A-4E63-B2D9-FB600E559028Q36843601-88173824-324D-472E-948E-44931DE47617Q36921100-3762F938-F824-45A6-8734-FA3A189E7DA3Q37019388-8652A170-5620-47AA-B0D8-663CD3094C4DQ37760092-3E3D9B65-B161-4F79-98BE-F0BF02AE8905Q37851768-B7E091DD-CD0A-40E3-8E57-9210FCE3E294Q38109239-2EB9CFBB-22EB-482D-AB9B-F66AD5E0A592Q38203504-6527F97E-6536-4997-A3BA-222C66A5771AQ38203574-F0828E96-96FC-44A3-94BF-00981B17CF13Q38617421-E8D2BA12-8ECD-4412-B54D-E2689B531D39Q39151222-4CBED73D-9DDF-472D-A2F2-C36D724CA522Q41508243-DB840C38-6166-41AC-BE1E-D7EF3F08C714Q42675947-5C0465DA-954E-40B7-B57F-DC6B0080FF9DQ42905444-28A190E9-B2AE-49F6-A8B4-7F95A44B03CDQ42961382-AEC51EC6-16DC-4345-ACFF-87D8F1B46B39
P2860
Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Opioid-induced second window o ...... f mitochondrial KATP channels.
@en
Opioid-induced second window o ...... f mitochondrial KATP channels.
@nl
type
label
Opioid-induced second window o ...... f mitochondrial KATP channels.
@en
Opioid-induced second window o ...... f mitochondrial KATP channels.
@nl
prefLabel
Opioid-induced second window o ...... f mitochondrial KATP channels.
@en
Opioid-induced second window o ...... f mitochondrial KATP channels.
@nl
P2093
P356
P1433
P1476
Opioid-induced second window o ...... f mitochondrial KATP channels.
@en
P2093
P304
P356
10.1161/01.RES.84.7.846
P577
1999-04-01T00:00:00Z